Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Sidoti & Co. Downgrades Steelcase to Neutral

Sidoti & Co. analyst Gregory Burns downgrades Steelcase (NYSE:SCS) from Buy to Neutral.
byBenzinga Newsdesk
September 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Sidoti & Co. analyst Gregory Burns downgrades Steelcase (NYSE:SCS) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Regeneron and Sanofi Announced Dupixent Late-Breaking Phase 3 Data Presented at UEG Week 2022 Showed Significant Histological Remission of Eosinophilic Esophagitis in Children 1 to 11

By Charles Gross
October 11, 4:52 AM
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today presented late-breaking positive results from a Phase 3 trial evaluating the investigational use of Dupixent® (dupilumab) in children aged 1 to 11 years with active eosinophilic esophagitis (EoE).

REGN